Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update showing completion of a safety and pharmacokinetics study of BX-001N in healthy participants, with the ischemia-reperfusion injury indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• BX-001N

Snippet

Sponsor: Bilix Co.,Ltd. | Conditions: Ischemia-reperfusion Injury | Phase 1 | Status: COMPLETED